Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|December 19, 2001
Low basal androstenedione levels plus augmented 17alpha-hydroxyprogesterone and low dehydroepiandrosterone sulfate responses to adrenocorticotropic hormone stimulation in patients with adrenal incidentalomaA G Ozgen, F Bayraktar, C Yilmaz
Endocrine Journal|July 30, 1999
The 4A syndrome association with osteoporosisA G Ozgen, E Ercan, O Ozütemiz, et al.
Eating and Weight Disorders : EWD|March 10, 2001
Acarbose treatment in obesity: a controlled studyF Bayraktar, F Hamulu, A G Ozgen, et al.
Rheumatology International|May 31, 2002
Spontaneous bilateral perirenal hematoma as a complication of polyarteritis nodosa in a patient with human immunodeficiency virus infectionA Sagcan, E Tunc, G Keser, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004
Triiodothyronine antibodies in patients with goiterA G Ozgen, T Kabalak, F Hamulu, et al.
Eating and Weight Disorders : EWD|March 23, 2000
Long-term treatment with acarbose for the treatment of reactive hypoglycemiaA G Ozgen, F Hamulu, F Bayraktar, et al.
Thyroid : Official Journal of the American Thyroid Association|July 20, 1999
Evaluation of routine basal serum calcitonin measurement for early diagnosis of medullary thyroid carcinoma in seven hundred seventy-three patients with nodular goiterA G Ozgen, F Hamulu, F Bayraktar, et al.
Diabetes Research and Clinical Practice|October 4, 2006
Transforming growth factor-beta 1 levels in women with prior history of gestational diabetes mellitusS Yener, T Demir, B Akinci, et al.
Journal of Endocrinological Investigation|June 23, 2009
Prospective evaluation of tumor size and hormonal status in adrenal incidentalomasS Yener, S Ertilav, M Secil, et al.
Journal of Endocrinological Investigation|December 14, 2007
Plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor levels in non-alcoholic steatohepatitisS Yener, M Akarsu, T Demir, et al.
Pageof 2